Westminister, CO, United States of America

Michael Brian Welch

USPTO Granted Patents = 3 

Average Co-Inventor Count = 19.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Westminister, CO (US) (2023)
  • Westminster, CO (US) (2024)

Company Filing History:


Years Active: 2023-2024

Loading Chart...
3 patents (USPTO):

Title: Inventor Spotlight: Michael Brian Welch

Introduction

Michael Brian Welch is an innovative inventor based in Westminster, Colorado. He holds three patents that contribute significantly to advancements in the field of pharmaceuticals, specifically targeting diseases through novel compounds.

Latest Patents

His latest patents involve allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K), which are crucial for treating various diseases associated with PI3K modulation. The compounds, represented by Formula (I), are defined with specific configurations where R, R, R, R, R, R, R, R, and R represent various elements as detailed in his disclosures. These inventive compounds also encompass methods of synthesis and applications that highlight their therapeutic potential.

Career Highlights

Michael is affiliated with Petra Pharma Corporation, where he continues to push the boundaries of medical innovation. His expertise and dedication to developing effective treatments underscore his commitment to improving healthcare outcomes through inventive solutions.

Collaborations

Throughout his career, Michael has had the privilege of collaborating with talented individuals, including coworkers Erin Danielle Anderson and Sean Douglas Aronow. Their collective efforts contribute to the dynamic environment at Petra Pharma Corporation, fostering innovation and progress.

Conclusion

Michael Brian Welch exemplifies the spirit of innovation, with his work in developing allosteric chromenone inhibitors for PI3K offering promising therapeutic approaches to tackling complex diseases. His contributions not only reflect his inventiveness but also highlight the importance of collaboration in driving meaningful advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…